Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462904 · ClinicalTrials.gov registry record · Phase 2
Pharmacokinetic Response to BPI in Burns
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT00462904 is a Phase 2 study that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 4 participants.
The verdict
NCT00462904, a Phase 2 study, was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of a protein called BPI that is naturally made by the body's white blood cells to fight infection.
Interventions
- DRUG BPI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00462904
The ClinicalTrials.gov registry entry for NCT00462904 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BPI is the first listed.
NCT00462904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00462904 about?
NCT00462904 is a clinical study titled "Pharmacokinetic Response to BPI in Burns". The purpose of this study is to evaluate the safety of a protein called BPI that is naturally made by the body's white blood cells to fight infection.
What is the current status of trial NCT00462904?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2006-04. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00462904?
The interventions under investigation include: BPI (DRUG).
Who is sponsoring clinical trial NCT00462904?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.